drugset / Trial / NCT02532777
The Research of Standard Diagnosis and Treatment for HSPN in Children
RandomizedParallel-groupSingle-blindTreatment
Summary
This study is performed to evaluate the efficacy and safety of various measures in the treatment of HSPN in children.
Timeline
- Start
- 2015-08
- Primary completion
- 2020-07
- Completion
- 2020-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | 0.1 mg/kg | Intravenous |
| Subject | Leflunomide | Small molecule | 0.5 mg/kg | Oral |
| Subject | Mycophenolate Mofetil | Small molecule | 25 mg/kg | Oral |
| Background | Methylprednisolone | Other / unclassified | — | — |
| Background | Prednisone | Other / unclassified | 2 mg/kg | — |